| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)
|
Kawabata, Ryohei
|
|
|
18 |
3 |
p. 359-368
|
article
|
| 2 |
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer
|
De La Cerda, Jose
|
|
|
18 |
3 |
p. 383-390
|
article
|
| 3 |
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
|
Chee, Cheng E.
|
|
|
18 |
3 |
p. 391-402
|
article
|
| 4 |
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial
|
Izawa, Naoki
|
|
|
18 |
3 |
p. 369-381
|
article
|
| 5 |
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
|
ter Heine, Rob
|
|
|
18 |
3 |
p. 441-450
|
article
|
| 6 |
Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial
|
Williams, Steven C. R.
|
|
|
18 |
3 |
p. 403-413
|
article
|
| 7 |
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
|
Chamorro, Diego F.
|
|
|
18 |
3 |
p. 425-440
|
article
|
| 8 |
HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast
|
Bardia, Aditya
|
|
|
18 |
3 |
p. 313-319
|
article
|
| 9 |
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
|
Mohammadi, Mahmoud
|
|
|
18 |
3 |
p. 415-423
|
article
|
| 10 |
Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
|
Zhao, Melody
|
|
|
18 |
3 |
p. 327-358
|
article
|
| 11 |
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast
|
Brufsky, Adam
|
|
|
18 |
3 |
p. 321-326
|
article
|
| 12 |
Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
|
Nie, Tina
|
|
|
18 |
3 |
p. 463-470
|
article
|
| 13 |
Uncovering the Burden of Immune-Related Adverse Events in Immunotherapy: Insights from a Nationally Representative Sample
|
Pichardo, Rayli
|
|
|
18 |
3 |
p. 451-461
|
article
|
Journal description